JP2003510359A5 - - Google Patents

Download PDF

Info

Publication number
JP2003510359A5
JP2003510359A5 JP2001527795A JP2001527795A JP2003510359A5 JP 2003510359 A5 JP2003510359 A5 JP 2003510359A5 JP 2001527795 A JP2001527795 A JP 2001527795A JP 2001527795 A JP2001527795 A JP 2001527795A JP 2003510359 A5 JP2003510359 A5 JP 2003510359A5
Authority
JP
Japan
Prior art keywords
anilino
triazole
methyl
benzylthio
ylthio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001527795A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003510359A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/026951 external-priority patent/WO2001024796A1/en
Publication of JP2003510359A publication Critical patent/JP2003510359A/ja
Publication of JP2003510359A5 publication Critical patent/JP2003510359A5/ja
Pending legal-status Critical Current

Links

JP2001527795A 1999-10-01 2000-09-29 化合物および方法 Pending JP2003510359A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15728699P 1999-10-01 1999-10-01
US60/157,286 1999-10-01
PCT/US2000/026951 WO2001024796A1 (en) 1999-10-01 2000-09-29 1,2,4-triazole derivatives, composition, process of making and methods of use

Publications (2)

Publication Number Publication Date
JP2003510359A JP2003510359A (ja) 2003-03-18
JP2003510359A5 true JP2003510359A5 (https=) 2007-11-22

Family

ID=22563095

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001527795A Pending JP2003510359A (ja) 1999-10-01 2000-09-29 化合物および方法

Country Status (5)

Country Link
US (1) US7304082B2 (https=)
EP (1) EP1223932A4 (https=)
JP (1) JP2003510359A (https=)
AU (1) AU7989400A (https=)
WO (1) WO2001024796A1 (https=)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1381360A4 (en) * 2001-03-29 2009-12-02 Smithkline Beecham Corp COMPOUNDS AND METHODS FOR INHIBITING METAP2 IN MAMMALS
AU2003223357A1 (en) * 2002-03-27 2003-10-13 Smithkline Beecham Corporation Compounds and methods
IL166510A0 (en) * 2002-08-09 2006-01-15 Nps Pharma Inc 1,2,4"oxadiazole as modulators of metabotropic glutamate receptor-5
FR2862060A1 (fr) * 2003-11-06 2005-05-13 Galderma Res & Dev Procede de synthese en phase solide de composes de types sulfures de diaryle.
EP2026797A2 (en) * 2006-05-25 2009-02-25 Synta Pharmaceuticals Corporation Method for treating non-hodgkin's lymphoma
EP2170402B1 (en) 2007-06-26 2015-03-25 Children's Medical Center Corporation Metap-2 inhibitor polymersomes for therapeutic administration
WO2013055385A2 (en) 2011-10-03 2013-04-18 Zafgen Corporation Methods of treating age related disorders
CA2777108A1 (en) 2009-10-09 2011-04-14 Zafgen Corporation Sulphone compounds and methods of making and using same
US8815309B2 (en) 2010-01-08 2014-08-26 Zafgen, Inc. Methods of treating a subject with benign prostate hyperplasia
WO2011088055A2 (en) 2010-01-12 2011-07-21 Zafgen Corporation Methods and compositions for treating cardiovascular disorders
WO2011127304A2 (en) 2010-04-07 2011-10-13 Zafgen Corporation Methods of treating an overweight subject
US9205086B2 (en) 2010-04-19 2015-12-08 Synta Pharmaceuticals Corp. Cancer therapy using a combination of a Hsp90 inhibitory compounds and a EGFR inhibitor
CN103249735B (zh) * 2010-07-22 2016-04-06 扎夫根股份有限公司 三环化合物及其制备和使用方法
WO2012064928A1 (en) 2010-11-10 2012-05-18 Zafgen Corporation Methods and compositions for treating thyroid hormone related disorders
WO2012074968A1 (en) 2010-11-29 2012-06-07 Zafgen Corporation Methods of reducing risk of hepatobiliary dysfunction during rapid weight loss with metap-2 inhibitors
US9189078B2 (en) 2010-12-20 2015-11-17 Apple Inc. Enhancing keycap legend visibility with optical components
MX344238B (es) 2011-01-26 2016-12-07 Zafgen Inc Compuestos de tetrazol y métodos para preparar y usar los mismos.
CN103764641B (zh) 2011-05-06 2016-10-26 扎夫根股份有限公司 部分饱和的三环化合物及其制备和使用方法
EP2705036B1 (en) 2011-05-06 2015-08-12 Zafgen Inc. Tricyclic sulfonamide compounds and methods of making and using same
BR112013028666A2 (pt) 2011-05-06 2017-08-08 Zafgen Inc compostos de pirazolo sulfonamida tricícilos e métodos para fazer e usar o mesmo
AU2012332424A1 (en) 2011-11-02 2014-06-05 Synta Pharmaceuticals Corp. Combination therapy of Hsp90 inhibitors with platinum-containing agents
EP2773345A1 (en) 2011-11-02 2014-09-10 Synta Pharmaceuticals Corp. Cancer therapy using a combination of hsp90 inhibitors with topoisomerase i inhibitors
WO2013074594A1 (en) 2011-11-14 2013-05-23 Synta Pharmaceuticals Corp. Combination therapy of hsp90 inhibitors with braf inhibitors
MX2014008706A (es) 2012-01-18 2015-03-05 Zafgen Inc Compuestos tricíclicos de sulfonamida y métodos para elaborarlos y usarlos.
JP2015509102A (ja) 2012-01-18 2015-03-26 ザフゲン,インコーポレイテッド 三環式スルホン化合物並びにその作製および使用方法
MX2014013599A (es) 2012-05-08 2015-05-11 Zafgen Inc Tratamiento de la obesidad hipotalamica con inhibidores de metap2.
BR112014027981A2 (pt) 2012-05-09 2017-06-27 Zafgen Inc compostos do tipo fumagilol e métodos de produção e utilização dos mesmos
NZ707773A (en) 2012-11-05 2019-05-31 Zafgen Inc Methods of treating liver diseases
AU2013337282A1 (en) 2012-11-05 2015-05-21 Zafgen, Inc. Tricyclic compounds and methods of making and using same
MX2015005733A (es) 2012-11-05 2016-02-10 Zafgen Inc Compuestos triciclicos para usarse en el tratamiento y/o control de obesidad.
CN105228610A (zh) 2013-03-14 2016-01-06 扎夫根股份有限公司 治疗肾疾病和其它病症的方法
WO2015089800A1 (en) 2013-12-19 2015-06-25 Eli Lilly And Company Fluorophenyl pyrazol compounds
US10323016B2 (en) * 2014-06-12 2019-06-18 Universite De Lille 2 Droit Et Sante Imidazol- or 1,2,4-triazol-derivatives and their use
CN106432255A (zh) 2015-08-11 2017-02-22 扎夫根公司 烟曲霉素醇螺环化合物和制备和使用其的方法
AR105671A1 (es) 2015-08-11 2017-10-25 Zafgen Inc Compuestos heterocíclicos de fumagillol y sus métodos de elaboración y uso
MX2020011501A (es) * 2018-05-04 2020-12-07 Inflazome Ltd Compuestos novedosos.

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55120571A (en) * 1979-03-02 1980-09-17 Glaxo Group Ltd Heterocyclic derivative
CH655104A5 (fr) * 1980-02-28 1986-03-27 Glaxo Group Ltd Derives heterocycliques triazoliques, procedes pour leur preparation et compositions pharmaceutiques les comportant.
HU191475B (en) * 1982-09-01 1987-02-27 Gyogyszerkutato Intezet Process for producing new acylized 1,2,4-triazole derivatives
US4760448A (en) * 1987-05-04 1988-07-26 Sencore, Inc. Method of measuring amplitude variations of a video carrier and apparatus therefor
JPH01160972A (ja) * 1987-12-18 1989-06-23 Tsumura & Co 1,2,4−トリアゾール誘導体及びそれを有効成分として含有する抗潰瘍剤
DE4142366A1 (de) 1991-07-15 1993-06-24 Thomae Gmbh Dr K Phenylalkylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
GB9207396D0 (en) 1992-04-03 1992-05-13 Merck Sharp & Dohme Therapeutic agents
DE4424787A1 (de) 1994-07-14 1996-01-18 Bayer Ag Substituierte Aryliminoheterocyclen
DE4425144A1 (de) 1994-07-15 1996-01-18 Basf Ag Triazolverbindungen und deren Verwendung
DK0794957T3 (da) * 1994-11-29 1999-10-25 Lonza Ag Fremgangsmåde til fremstilling af optisk aktive metallocenylphosphiner
US5798374A (en) * 1995-06-07 1998-08-25 Sugen Inc. Methods of inhibiting phosphatase activity and treatment of disorders associated therewith
US20020168761A1 (en) * 2000-01-24 2002-11-14 Gour Barbara J. Peptidomimetic modulators of cell adhesion
US5760246A (en) * 1996-12-17 1998-06-02 Biller; Scott A. Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
WO1998056372A1 (en) * 1997-06-09 1998-12-17 Massachusetts Institute Of Technology TYPE 2 METHIONINE AMINOPEPTIDASE (MetAP2) INHIBITORS AND USES THEROF
DE19922443A1 (de) * 1999-05-07 2000-11-09 Basf Ag Verwendung von Dopamin-D3-Rezeptorliganden zur Herstellung von Arzneimittel für die Behandlung von Nierenfunktionsstörungen
DE19921567A1 (de) * 1999-05-11 2000-11-16 Basf Ag Verwendung von Phthalazine-Derivaten
WO2001036404A1 (en) 1999-11-19 2001-05-25 Smithkline Beecham Corporation Compounds and methods
HN2001000008A (es) * 2000-01-21 2003-12-11 Inc Agouron Pharmaceuticals Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
US20030220371A1 (en) * 2000-04-12 2003-11-27 Kallander Lara S. Compounds and methods
AU2001278951A1 (en) 2000-07-19 2002-01-30 Smith Kline Beecham Corporation Compounds and methods
US20060247280A1 (en) 2001-03-29 2006-11-02 Marino Joseph P Jr Compounds and methods
JP2004525942A (ja) 2001-03-29 2004-08-26 スミスクライン・ビーチャム・コーポレイション 化合物および方法
AU2002306907A1 (en) 2001-04-03 2002-10-21 Smithkline Beecham Corporation Method for inhibiting metap2
WO2003031434A1 (en) 2001-10-12 2003-04-17 Smith Kline Beecham Corporation Compounds and methods
WO2003051906A2 (en) 2001-12-14 2003-06-26 Smithkline Beecham Corporation Compounds and methods
JP2003281388A (ja) 2002-03-25 2003-10-03 Hitachi Ltd 自動取引装置
AU2003223357A1 (en) 2002-03-27 2003-10-13 Smithkline Beecham Corporation Compounds and methods
US20040116490A1 (en) 2002-03-28 2004-06-17 Marino Jr. Joseph P. Compounds and methods

Similar Documents

Publication Publication Date Title
JP2003510359A5 (https=)
JP2004520292A5 (https=)
RU2006127575A (ru) Соединение триазола и их применение в качестве антагонистов метаботропного рецептора глутамата
JP2019077725A5 (https=)
JP2020516671A5 (https=)
JP2007523181A5 (https=)
RU2003118448A (ru) Производные замещенного триазолдиамина и их применение в качестве ингибиторов киназы
JP2004523535A5 (https=)
JP2005511608A5 (https=)
US20090054491A1 (en) Use
RU2006127572A (ru) Полигетероциклические соединения и их применение в качестве антагонистов метаботропного рецептора глутамата
JP2010505809A5 (https=)
JP2009519965A5 (https=)
JP2007511485A5 (https=)
JP2006524686A5 (https=)
JP2006506380A5 (https=)
JPWO2021170109A5 (https=)
JP2006507355A5 (https=)
JP2011527675A5 (https=)
JP2002505286A5 (https=)
JP2004525184A5 (https=)
JP2004525183A5 (https=)
CA2465757A1 (en) Triazole derivatives as cyclooxygenase (cox) inhibitors
JP2004521150A5 (https=)
RU2425045C2 (ru) Производные арил-изоксазол-4-ил-имидазола